Other
Fractures
0
Pipeline Programs↗
5
Active Trials↗
5
Companies Involved↗
Fractures is an early-stage landscape with 0 programs across 5 companies. The most active players are Pfizer, GSK, Amgen.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
25
clinical trials
Completed12 · 48%
Terminated5 · 20%
Recruiting4 · 16%
Unknown status2 · 8%
Withdrawn1 · 4%
Not yet recruiting1 · 4%
Clinical Trials
Trial Activity
25 trials
A Post-market Study Evaluating Clinical and Safety Outcomes of Bipolar Hemiarthroplasty Using CoCrMo LOCK Bipolar Femoral Heads in Subjects With Hip Fracture
Recruiting·—·N/A·NCT06885359·60 enrolled
Pain Alleviation of Forearm Fractures
Completed·—·N/A·NCT03377907·66 enrolled
FARE Augmentation of Proximal Femoral Fractures With CaS/HA and Systemic ZA
Completed·—·Phase 4·NCT06135298·20 enrolled
Pain Palliation in Forearm Fractures in the Emergency Department
Completed·—·N/A·NCT06588907·85 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)